Sphingosine kinase 1 is regulated via E2Fs in oral squamous cell carcinoma
Reports of Practical Oncology and Radiotherapy · 31.07.2026
DOI: 10.5603/rpor.113779 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reports of Practical Oncology and Radiotherapy, online erschienen am 31.07.2026. Verfasst von Ritu Pandey und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Sphingosine kinase 1 (SphK1) is elevated in a variety of cancers, including oral squamous cell carcinoma (OSCC), which is the third most prevalent cancer in India. However, its molecular regulation at the transcriptional level remains enigmatic. The E2 factor (E2F) family of transcription factors, key regulators of cell cycle and cancer-related gene expression, may contribute to SphK1 upregulation, offering potential insights into novel regulatory mechanisms and therapeutic targets. Materials and methods: Oral squamous cell carcinoma tissue samples along with adjacent healthy tissues were collected intra-op and snap-frozen. RNA was extracted and quantitative real-time polymerase chain reaction (PCR) was used to identify the expression of E2F1 & E2F7 affecting SPHK1 expression. To validate transcriptional regulation, E2F1/E2F7 was knocked down in OSCC cell lines via small interfering RNA (siRNA) and expression of SphK1 was quantified. Additionally, SPHK1 promoter activity was assessed with a luciferase reporter assay following E2F1 or E2F7 knockdown to determine their functional impact on SphK1 transcription.
Results
Our results showed that the mRNA levels of E2F1 and E2F7 were significantly higher in OSCC tumors tissues than in normal tissues. Elevated expression of E2F1 and E2F7 positively correlated with the mRNA levels of SPHK1 in OSCC tumor tissues. In OSCC cell lines, silencing of E2F1 increased SphK1 promoter activity, whereas silencing E2F7 resulted in reduced promoter activity.
Conclusions
The expression of E2F1 and E2F7 was elevated in OSCC tissue when compared with adjacent normal tissue. Further, the expression of E2F1 and E2F7 strongly correlates with the expression of SphK1. Further in vitro experiments suggest that E2F1 act as a repressor of SPHK1.
Zitieren
APA
Pandey, R., Vishwakarma, S., Gupta, V., Arya, N., Das, S., Joshi, D., & Kumar, A. (2026). Sphingosine kinase 1 is regulated via E2Fs in oral squamous cell carcinoma. Reports of Practical Oncology and Radiotherapy. https://doi.org/10.5603/rpor.113779
Vancouver
Pandey R, Vishwakarma S, Gupta V, Arya N, Das S, Joshi D, et al. Sphingosine kinase 1 is regulated via E2Fs in oral squamous cell carcinoma. Reports of Practical Oncology and Radiotherapy. 2026. doi:10.5603/rpor.113779
BibTeX
@article{Pandey2026,
author = {Pandey, Ritu and Vishwakarma, Supriya and Gupta, Vikas and Arya, Neha and Das, Saikat and Joshi, Deepti and Kumar, Ashok},
title = {Sphingosine kinase 1 is regulated via E2Fs in oral squamous cell carcinoma},
journal = {Reports of Practical Oncology and Radiotherapy},
year = {2026},
doi = {10.5603/rpor.113779}
}
EUVIMED